✦ LIBER ✦

Prolonged Anticoagulation After Discontinuation of Argatroban and Warfarin Therapy in an Obese Patient with Heparin-Induced Thrombocytopenia

✍ Scribed by Nancy L. Shapiro; Emily A. Durr; Courtney D. Krueger

Book ID: 115049210
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 67 KB
Volume: 26
Category: Article
ISSN: 0277-0008
DOI: 10.1592/phco.26.12.1806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Argatroban anticoagulation for renal rep

Argatroban anticoagulation for renal replacement therapy in patients with heparin-induced thrombocytopenia after cardiovascular surgery

✍ Andreas Koster; Thomas Hentschel; Tom Groman; Hermann Kuppe; Roland Hetzer; Seba 📂 Article 📅 2007 🏛 CTSNet 🌐 English ⚖ 60 KB

Argatroban and renal replacement therapy

Argatroban and renal replacement therapy in a morbidly obese patient with heparin-induced thrombocytopenia: A case report

✍ Anne Godier; Claire Flaujac; Marie-Hélène Horellou; Marine De Mesmay; Xavier Béc 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Evaluation of Diagnostic Tests and Argat

Evaluation of Diagnostic Tests and Argatroban or Lepirudin Therapy in Patients with Suspected Heparin-Induced Thrombocytopenia

✍ Tyree H. Kiser; Rose Jung; Robert MacLaren; Douglas N. Fish 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Transitioning from Argatroban to Warfari

Transitioning from Argatroban to Warfarin in Heparin-Induced Thrombocytopenia: An Analysis of Outcomes in Patients with Elevated International Normalized Ratio (INR)

✍ John R. Bartholomew; Marcie J. Hursting 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 210 KB

Prolonged half-life of argatroban in pat

Prolonged half-life of argatroban in patients with renal dysfunction and antiphospholipid antibody syndrome being treated for heparin-induced thrombocytopenia

✍ Uzma Athar; Juhi Husain; Jane Hudson; Jennie Lynch; Ajeet Gajra 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

Report of successful use of argatroban a

Report of successful use of argatroban as an alternative anticoagulant during coronary stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome

✍ Lewis, Bruce E. ;Iaffaldano, Robert ;McKiernan, Thomas L. ;Rao, Luxman ;Donkin, 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 2 views

Heparin-induced thrombocytopenia and thrombosis syndrome (HITTS) is a severe complication of heparin caused by an antibody response to the heparin-platelet factor 4 complex which results in severe thrombosis. Heparin rechallenge in HllTS patients carries a high risk of inducing thrombosis. Antithrom